While many pharma companies are actively working on initiatives to improve diversity in clinical trials, we still have a long way to go. The good news is that technology is being harnessed to ...

For example, a DAP must be prepared for pivotal trials of a new drug, although, the regulator also recommends that sponsors develop a diversity strategy “across the entire clinical development ...

According to a Boston University study head and neck cancer (HNC) trials have been less diverse between 2000 and 2023.

This historical context provides an important lens for analyzing diversity proposals and their bearing on device trials in the field of stroke neurology. Despite economic and logistical challenges, ...